HDAC7 promotes renal cancer progression by reprogramming branched-chain amino acid metabolism
Science Advances · 06.06.2025 · 11 (23)
DOI: 10.1126/sciadv.adt3552 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, erschienen am 06.06.2025. Verfasst von Hyeyoung Nam und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, University of Alabama at Birmingham, Birmingham, AL, USA. Hauptthemen laut MEDLINE: Amino Acids, Branched-Chain, Kidney Neoplasms, Histone Deacetylases, Carcinoma, Renal Cell. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, BLRD VA.
Abstract (Originalsprache)
Clear cell renal cell carcinoma (ccRCC), the most common subtype of kidney cancer, exhibits notable metabolic reprogramming. We previously reported elevated HDAC7, a class II histone deacetylase, in ccRCC. Here, we demonstrate that HDAC7 promotes aggressive phenotypes and in vivo tumor progression in RCC. HDAC7 suppresses the expression of genes mediating branched-chain amino acid (BCAA) catabolism. Notably, lower expression of BCAA catabolism genes is strongly associated with worsened survival in ccRCC. Suppression of BCAA catabolism promotes expression of SNAIL1, a central mediator of aggressive phenotypes including migration and invasion. HDAC7-mediated suppression of the BCAA catabolic program promotes SNAI1 messenger RNA transcription via NOTCH signaling activation. Collectively, our findings provide innovative insights into the role of metabolic remodeling in ccRCC tumor progression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Urology, University of Alabama at Birmingham, Birmingham, AL, USA.
- Department of Urology and the University of Arizona Cancer Center, University of Arizona, Tucson, AZ, USA.
- Department of Pathology, University of Alabama at Birmingham, Birmingham, AL, USA.
- Department of Microbiology, University of Alabama at Birmingham, Birmingham, AL, USA.
- Sarah W. Stedman Nutrition and Metabolism Center and Duke Molecular Physiology Institute, Duke University, Durham, NC, USA.
- Department of Medicine, Division of Endocrinology, Metabolism and Nutrition, Duke University Medical Center, Durham, NC, USA.
ORCID-Profile: Hyeyoung Nam, Anirban Kundu, Suman Karki, Richard L Kirkman, Darshan S Chandrashekar, Jeremy B Foote, Guofang Zhang, Sooryanarayana Varambally, Han-Fei Ding, Sunil Sudarshan
Förderung
- NCI NIH HHS
- BLRD VA
Zitieren
APA
Nam, H., Kundu, A., Karki, S., Kirkman, R. L., Chandrashekar, D. S., Foote, J. B., Zhang, G., He, W., Varambally, S., Ding, H. F., & Sudarshan, S. (2025). HDAC7 promotes renal cancer progression by reprogramming branched-chain amino acid metabolism. Science Advances, 11(23). https://doi.org/10.1126/sciadv.adt3552
Vancouver
Nam H, Kundu A, Karki S, Kirkman RL, Chandrashekar DS, Foote JB, et al. HDAC7 promotes renal cancer progression by reprogramming branched-chain amino acid metabolism. Science Advances. 2025;11(23). doi:10.1126/sciadv.adt3552
BibTeX
@article{Nam2025,
author = {Nam, Hyeyoung and Kundu, Anirban and Karki, Suman and Kirkman, Richard L and Chandrashekar, Darshan S and Foote, Jeremy B and Zhang, Guofang and He, Wentao and Varambally, Sooryanarayana and Ding, Han-Fei and Sudarshan, Sunil},
title = {HDAC7 promotes renal cancer progression by reprogramming branched-chain amino acid metabolism},
journal = {Science Advances},
year = {2025},
volume = {11},
number = {23},
doi = {10.1126/sciadv.adt3552}
}
EUVIMED